Immutep: Advances phase two efti study for COVID-19 patients
Immutep's (IMM) phase two Eftilagimod Alpha Treatment COVID (EAT COVID) study will soon advance to enrolment ahead of the randomised portion
Up to...
© 2026 FintechInshorts. All Rights Reserved.

